Cited by 469Pancreatitis Pathology and TreatmentIgG4-Related and Inflammatory DiseasesPancreatic and Hepatic Oncology Research

Chronic pancreatitis

Open access
Braganza, Joan M, Lee, Stephen H, McCloy, Rory F, McMahon, Michael J·2011·The Lancet

Abstract

Chronic pancreatitis is a progressive fibroinflammatory disease that exists in large-duct (often with intraductal calculi) or small-duct form. In many patients this disease results from a complex mix of environmental (eg, alcohol, cigarettes, and occupational chemicals) and genetic factors (eg, mutation in a trypsin-controlling gene or the cystic fibrosis transmembrane conductance regulator); a few patients have hereditary or autoimmune disease. Pain in the form of recurrent attacks of pancreatitis (representing paralysis of apical exocytosis in acinar cells) or constant and disabling pain is usually the main symptom. Management of the pain is mainly empirical, involving potent analgesics, duct drainage by endoscopic or surgical means, and partial or total pancreatectomy. However, steroids rapidly reduce symptoms in patients with autoimmune pancreatitis, and micronutrient therapy to correct electrophilic stress is emerging as a promising treatment in the other patients. Steatorrhoea, diabetes, local complications, and psychosocial issues associated with the disease are additional therapeutic challenges.

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(10)61852-1

Cites

122 of 122 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The pathogenesis is different for acute and chronic pancreatitis, but alcohol use has a significant impact on the pathophysiology of both and in the transition from acute to chronic pancreatitis.

    “The pathogenesis is different for acute and chronic pancreatitis, but alcohol use has a significant impact on the pathophysiology of both 298, 299, 300, 301, 302 and in the transition from acute to chronic pancreatitis (see 303 ).”
  • This process is mediated by sustained elevation of the cytosolic Ca2+ levels and results ultimately in releasing pancreatic enzymes into the interstitium and in chronic inflammation.

    “This process is mediated by sustained elevation of the cytosolic Ca2+ levels 307 and results ultimately in releasing pancreatic enzymes into the interstitium and in chronic inflammation 299.”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Braganza, J. M., Lee, S. H., McCloy, R. F., & McMahon, M. J.
Affiliations
  • Manchester Royal Infirmary (GB)
  • Lancashire Teaching Hospitals NHS Foundation Trust (GB)
  • University of Leeds (GB)
Corresponding author
Braganza, Joan M
Venue
The Lancet
Publisher
Elsevier BV
Published
2011-04
Volume
377
Issue
9772
Pages
1184-1197
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W4211115676
Cited by
469
References
122
Citations by year
2026: 12 · 2025: 13 · 2024: 14 · 2023: 19 · 2022: 27 · 2021: 29 · 2020: 24 · 2019: 32 · 2018: 27 · 2017: 49 · 2016: 50 · 2015: 41 · 2014: 41 · 2013: 45 · 2012: 36
FWCI
7.50
Type
journal article
Language
en
Open access
Locations
  • The Lancet (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Surgery › Pancreatitis Pathology and Treatment
  • Health Sciences › Medicine › Rheumatology › IgG4-Related and Inflammatory Diseases
  • Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
Keywords
chronic pancreatitis, fibroinflammatory disease, alcohol, smoking, occupational chemicals, cystic fibrosis transmembrane conductance regulator, hereditary pancreatitis, autoimmune pancreatitis, pancreatic pain, analgesia, endoscopic drainage, pancreatic resection, corticosteroids, micronutrient therapy, steatorrhea, diabetes mellitus, psychosocial problems
MeSH terms
Algorithms, Animals, Anti-Inflammatory Agents, Cholangiopancreatography, Endoscopic Retrograde, Diabetes Mellitus, Disease Models, Animal, Drainage, Fibrosis, Humans, Ischemia, Magnetic Resonance Imaging, Mutation, Pancreas, Pancreatectomy, Pancreaticojejunostomy, Prednisolone, Risk Factors, Smoking, Biomarkers, Autoimmunity, Abdominal Pain, Endoscopy, Digestive System, Disease Progression, Micronutrients, Pancreatitis, Acute Necrotizing, Pancreatitis, Alcoholic, Genetic Predisposition to Disease, Steatorrhea, Pancreatitis, Chronic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review